5,300,000 SHARES FLUIDIGM CORPORATION COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 17th, 2008 • Fluidigm Corp • Laboratory analytical instruments • New York
Loan and Security AgreementsLoan and Security Agreement • September 17th, 2008 • Fluidigm Corp • Laboratory analytical instruments • California
This Loan and Security Agreement No. 4561 (this “Agreement”) is entered into as of March 29, 2005, by and between Lighthouse Capital Partners V, L.P. (“Lender”) and Fluidigm Corporation, a California corporation (“Borrower” or sometimes referred to herein as “Debtor”) and sets forth the terms and conditions upon which Lender will lend and Borrower will repay money. In consideration of the mutual covenants herein contained, the parties agree as follows:
MASTER CLOSING AGREEMENT By and Among FLUIDIGM CORPORATION, a California corporation, OCULUS PHARMACEUTICALS, INC., a Delaware corporation, and THE UAB RESEARCH FOUNDATION dated March 7, 2003Master Closing Agreement • September 17th, 2008 • Fluidigm Corp • Laboratory analytical instruments • Alabama
THIS MASTER CLOSING AGREEMENT is entered into as of March 7, 2003 by and among FLUIDIGM CORPORATION, a California corporation (“Fluidigm”), OCULUS PHARMACEUTICALS, INC., a Delaware corporation (“Oculus”), and THE UAB RESEARCH FOUNDATION (“UABRF”).
Fluidigm Corporation CONVERTIBLE NOTE PURCHASE AGREEMENT (US$15 Million Credit Facility) August 7, 2006Convertible Note Purchase Agreement • September 17th, 2008 • Fluidigm Corp • Laboratory analytical instruments • California
This Convertible Note Purchase Agreement (the “Agreement”) is made as of August 7, 2006, by and between Fluidigm Corporation, a California corporation (the “Company”), and Biomedical Sciences Investment Fund Pte Ltd (“Purchaser”).
